Shares of N4 Pharma Plc (LON:N4P – Get Free Report) traded up 3% during mid-day trading on Thursday . The company traded as high as GBX 0.90 ($0.01) and last traded at GBX 0.85 ($0.01). 649,204 shares changed hands during trading, a decline of 47% from the average session volume of 1,224,113 shares. The stock had previously closed at GBX 0.83 ($0.01).
N4 Pharma Stock Performance
The stock has a 50-day simple moving average of GBX 0.74 and a 200-day simple moving average of GBX 0.84. The stock has a market cap of £2.28 million, a PE ratio of -120.00 and a beta of -0.03. The company has a debt-to-equity ratio of 1.62, a current ratio of 27.88 and a quick ratio of 7.28.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than N4 Pharma
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Comprehensive PepsiCo Stock Analysis
- What is Insider Trading? What You Can Learn from Insider Trading
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Invest in the FAANG Stocks
- Bear Market Funds to Watch This Year
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
